X-37

X-37 is a cutting-edge pharmaceutical discovery and development company founded in 2018. The startup is focused on revolutionizing the pharmaceutical industry by leveraging advanced AI technology from Atomwise, Inc. to identify new drug candidates. Their groundbreaking approach involves scanning extensive libraries of chemical compounds against high-value pharmaceutical targets, which holds immense promise for the future of drug discovery. The most recent investment of $14.50M was secured in a Series A round from a consortium of prominent investors, including Alpha Intelligence Capital, Hemi Ventures, and DCVC Bio, on 14 November 2019. This significant financial backing underlines the confidence in X-37's vision and underscores their potential to make a substantial impact in the Health Care and Pharmaceutical industries.